Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease | Zendy

KA Jangaard | Zendy; D A Stinson | Zendy; Ac Allen | Zendy; MJ Vincer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease

Author(s) -

KA Jangaard,

D A Stinson,

Ac Allen,

MJ Vincer

Publication year - 2002

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/7.1.13

Subject(s) - medicine , respiratory distress , placebo , pediatrics , incidence (geometry) , bronchopulmonary dysplasia , anesthesia , neonatal intensive care unit , pregnancy , gestational age , physics , alternative medicine , pathology , biology , optics , genetics

Inflammation plays an important role in the development of chronic lung disease (CLD), which has become a major cause of morbidity in surviving infants less than 1250 g at birth. The authors hypothesized that the progression of this inflammation and, therefore, the establishment of CLD would be decreased with the use of early prophylactic inhaled corticosteroids. Short, and long term respiratory and neurodevelopmental outcomes were also examined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research